Semler Scientific (NASDAQ:SMLR – Get Free Report) and Pixie Dust Technologies (NASDAQ:PXDT – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, risk, institutional ownership, dividends, profitability, valuation and analyst recommendations.
Profitability
This table compares Semler Scientific and Pixie Dust Technologies’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Semler Scientific | 30.19% | 30.60% | 27.15% |
Pixie Dust Technologies | N/A | N/A | N/A |
Analyst Recommendations
This is a breakdown of recent ratings and recommmendations for Semler Scientific and Pixie Dust Technologies, as reported by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Semler Scientific | 0 | 0 | 0 | 0 | N/A |
Pixie Dust Technologies | 0 | 0 | 1 | 0 | 3.00 |
Valuation and Earnings
This table compares Semler Scientific and Pixie Dust Technologies’ gross revenue, earnings per share (EPS) and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Semler Scientific | $68.18 million | 2.67 | $20.58 million | $2.64 | 9.81 |
Pixie Dust Technologies | $5.18 million | 7.35 | -$14.45 million | N/A | N/A |
Semler Scientific has higher revenue and earnings than Pixie Dust Technologies.
Insider and Institutional Ownership
49.4% of Semler Scientific shares are owned by institutional investors. Comparatively, 0.4% of Pixie Dust Technologies shares are owned by institutional investors. 13.0% of Semler Scientific shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Summary
Semler Scientific beats Pixie Dust Technologies on 7 of the 10 factors compared between the two stocks.
About Semler Scientific
Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.
About Pixie Dust Technologies
Pixie Dust Technologies, Inc., a technology company, focuses on personal care and diversity, and workspace and digital transformation businesses primarily in Japan. It offers SonoRepro, an ultrasonic non-contact vibrotactile stimulation scalp care device; VUEVO, a series of directional voice arrival detection devices for individuals with deaf and hard-of-hearing; and kikippa, an acoustic stimulation device functioning as a desk-top speaker. The company also provides iwasemi, a sound-absorbing or sound-proofing material for architectural and interior design firms; hackke, a location positioning technology; KOTOWARI, a technology offering spatial analysis data; and magickiri, a planning services and monitoring service, which monitors human behavior and analyzes the customer's environment on the customer's behalf. In addition, it operates Pixie Nest, a membership forum, which hosts meetings and distributes information to facilitate solving social issues. The company was incorporated in 2017 and is headquartered in Tokyo, Japan.
Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.